UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 212

Sortiert nach

Immunogenetics of Disease-Causing Inflammation in Sarcoidosis

Clinical reviews in allergy & immunology, 2015-08, Vol.49 (1), p.19-35

2015

Volltextzugriff (PDF)

Immune cell activation and cytokine release after stimulation of whole blood with pneumococcal C-polysaccharide and capsular polysaccharides

International journal of infectious diseases, 2016-11, Vol.52, p.1-8

2016

Volltextzugriff (PDF)

Meta-analysis of hepatic cytochrome P450 ontogeny to underwrite the prediction of pediatric pharmacokinetics using physiologically based pharmacokinetic modeling

Journal of clinical pharmacology, 2016-03, Vol.56 (3), p.266-283

2016

Volltextzugriff (PDF)

Analysis of Chromosome 5q31–32 and Psoriasis: Confirmation of a Susceptibility Locus but no Association with SNPs within SLC22A4 and SLC22A5

Journal of investigative dermatology, 2006-05, Vol.126 (5), p.998-1002

2006

Volltextzugriff (PDF)

Absorption, Distribution, Metabolism, and Excretion of [ 14 C]-Sotorasib in Rats and Dogs: Interspecies Differences in Absorption, Protein Conjugation and Metabolism

Drug metabolism and disposition, 2022-05, Vol.50 (5), p.600-612

2022

Volltextzugriff (PDF)

Methylome and transcriptome signature of bronchoalveolar cells from multiple sclerosis patients in relation to smoking

Multiple sclerosis, 2021-06, Vol.27 (7), p.1014-1026

2021

Volltextzugriff (PDF)

Selection of alternative CYP3A4 probe substrates for clinical drug interaction studies using in vitro data and in vivo simulation

Drug metabolism and disposition, 2010-06, Vol.38 (6), p.981

2010

Volltextzugriff (PDF)

Strain-Dependent Variability of Early Discovery Small Molecule Pharmacokinetics in Mice: Does Strain Matter?

Drug metabolism and disposition, 2020-08, Vol.48 (8), p.613-621

2020

Volltextzugriff (PDF)

Prediction of CYP2D6 drug interactions from in vitro data: evidence for substrate-dependent inhibition

Drug metabolism and disposition, 2012-01, Vol.40 (1), p.47

2012

Volltextzugriff (PDF)

Genome-wide linkage scan for breast cancer susceptibility loci in Swedish hereditary non-BRCA1/2 families: Suggestive linkage to 10q23.32-q25.3

Genes chromosomes & cancer, 2007-03, Vol.46 (3), p.302-309

2007

Volltextzugriff (PDF)

Evaluation of CYP2C8 inhibition in vitro: utility of montelukast as a selective CYP2C8 probe substrate

Drug metabolism and disposition, 2011-09, Vol.39 (9), p.1546

2011

Volltextzugriff (PDF)

CYP2C19 inhibition: the impact of substrate probe selection on in vitro inhibition profiles

Drug metabolism and disposition, 2008-03, Vol.36 (3), p.523

2008

Volltextzugriff (PDF)

Searching for genes influencing a complex disease: the case of coeliac disease

European journal of human genetics : EJHG, 2008-05, Vol.16 (5), p.542-553

2008

Volltextzugriff (PDF)

Evaluation of levocetirizine in beagle dog and cynomolgus monkey telemetry assays: Defining the no QTc effect profile by timepoint and concentration‐QTc analysis

Clinical and translational science, 2023-03, Vol.16 (3), p.436-446

2023

Volltextzugriff (PDF)

CYP2C9 inhibition: impact of probe selection and pharmacogenetics on in vitro inhibition profiles

Drug metabolism and disposition, 2006-12, Vol.34 (12), p.1966

2006

Volltextzugriff (PDF)

Opinion on Directive 98/44/EC on the legal protection of biotechnical inventions, and its implementation in Sweden

Science and engineering ethics, 2005-01, Vol.11 (1), p.113-115

Wahlstrom, Jan

2005

Volltextzugriff (PDF)

Application of cytochrome P450 drug interaction screening in drug discovery

Combinatorial chemistry & high throughput screening, 2010-02, Vol.13 (2), p.145

2010

Volltextzugriff (PDF)

Mechanism-based inactivation of cytochrome P450 3A4 by mibefradil through heme destruction

Drug metabolism and disposition, 2011-07, Vol.39 (7), p.1188

2011

Volltextzugriff (PDF)

Risk of tuberculosis in a large sample of patients with coeliac disease – a nationwide cohort study

Alimentary pharmacology & therapeutics, 2011-03, Vol.33 (6), p.689-696

2011

Volltextzugriff (PDF)

In vitro inhibition of multiple cytochrome P450 isoforms by xanthone derivatives from mangosteen extract

Drug metabolism and disposition, 2009-09, Vol.37 (9), p.1848

2009

Volltextzugriff (PDF)

The in vitro drug interaction potential of dietary supplements containing multiple herbal components

Drug metabolism and disposition, 2007-02, Vol.35 (2), p.185

2007

Volltextzugriff (PDF)

Enzyme source effects on CYP2C9 kinetics and inhibition

Drug metabolism and disposition, 2006-11, Vol.34 (11), p.1903

2006

Volltextzugriff (PDF)

Reactivity to Mycobacterial Antigens by Patients with Löfgren's Syndrome as a Model of Phenotypic Susceptibility to Disease and Disease Progression

American journal of respiratory and critical care medicine, 2009-10, Vol.180 (7), p.685-686

2009

Volltextzugriff (PDF)

Differential Time-Dependent Inactivation of P450 3A4 and P450 3A5 by Raloxifene: A Key Role for C239 in Quenching Reactive Intermediates

Chemical research in toxicology, 2007-12, Vol.20 (12), p.1778-1786

2007

Volltextzugriff (PDF)

Ligand-Based Design of a Potent and Selective Inhibitor of Cytochrome P450 2C19

Journal of medicinal chemistry, 2012-02, Vol.55 (3), p.1205-1214

2012

Volltextzugriff (PDF)

1 – 25 von 212

Suche als RSS-Feed

Aktive Filter

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(181)
Mit Volltextzugriff
(168)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Immunogenetics of Disease-Causing Inflammation in Sarcoidosis

Immune cell activation and cytokine release after stimulation of whole blood with pneumococcal C-polysaccharide and capsular polysaccharides

Meta-analysis of hepatic cytochrome P450 ontogeny to underwrite the prediction of pediatric pharmacokinetics using physiologically based pharmacokinetic modeling

Analysis of Chromosome 5q31–32 and Psoriasis: Confirmation of a Susceptibility Locus but no Association with SNPs within SLC22A4 and SLC22A5

Absorption, Distribution, Metabolism, and Excretion of [ 14 C]-Sotorasib in Rats and Dogs: Interspecies Differences in Absorption, Protein Conjugation and Metabolism

Methylome and transcriptome signature of bronchoalveolar cells from multiple sclerosis patients in relation to smoking

Selection of alternative CYP3A4 probe substrates for clinical drug interaction studies using in vitro data and in vivo simulation

Strain-Dependent Variability of Early Discovery Small Molecule Pharmacokinetics in Mice: Does Strain Matter?

Prediction of CYP2D6 drug interactions from in vitro data: evidence for substrate-dependent inhibition

Genome-wide linkage scan for breast cancer susceptibility loci in Swedish hereditary non-BRCA1/2 families: Suggestive linkage to 10q23.32-q25.3

Evaluation of CYP2C8 inhibition in vitro: utility of montelukast as a selective CYP2C8 probe substrate

CYP2C19 inhibition: the impact of substrate probe selection on in vitro inhibition profiles

Searching for genes influencing a complex disease: the case of coeliac disease

Evaluation of levocetirizine in beagle dog and cynomolgus monkey telemetry assays: Defining the no QTc effect profile by timepoint and concentration‐QTc analysis

CYP2C9 inhibition: impact of probe selection and pharmacogenetics on in vitro inhibition profiles

Opinion on Directive 98/44/EC on the legal protection of biotechnical inventions, and its implementation in Sweden

Application of cytochrome P450 drug interaction screening in drug discovery

Mechanism-based inactivation of cytochrome P450 3A4 by mibefradil through heme destruction

Risk of tuberculosis in a large sample of patients with coeliac disease – a nationwide cohort study

In vitro inhibition of multiple cytochrome P450 isoforms by xanthone derivatives from mangosteen extract

The in vitro drug interaction potential of dietary supplements containing multiple herbal components

Enzyme source effects on CYP2C9 kinetics and inhibition

Reactivity to Mycobacterial Antigens by Patients with Löfgren's Syndrome as a Model of Phenotypic Susceptibility to Disease and Disease Progression

Differential Time-Dependent Inactivation of P450 3A4 and P450 3A5 by Raloxifene: A Key Role for C239 in Quenching Reactive Intermediates

Ligand-Based Design of a Potent and Selective Inhibitor of Cytochrome P450 2C19

Aktive Filter

Suchergebnisse filtern